Cargando…

Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity

Cancer is a major health problem. Most of the treatments exhibit systemic toxicity, as they are not targeted or specific to cancerous cells and tumors. Adenoviruses are very promising gene delivery vectors and have immense potential to deliver targeted therapy. Here, we review a wide range of strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajeri, Praveensingh B., Sharma, Nikita S., Yamamoto, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352392/
https://www.ncbi.nlm.nih.gov/pubmed/32526919
http://dx.doi.org/10.3390/cancers12061504
_version_ 1783557627356119040
author Hajeri, Praveensingh B.
Sharma, Nikita S.
Yamamoto, Masato
author_facet Hajeri, Praveensingh B.
Sharma, Nikita S.
Yamamoto, Masato
author_sort Hajeri, Praveensingh B.
collection PubMed
description Cancer is a major health problem. Most of the treatments exhibit systemic toxicity, as they are not targeted or specific to cancerous cells and tumors. Adenoviruses are very promising gene delivery vectors and have immense potential to deliver targeted therapy. Here, we review a wide range of strategies that have been tried, tested, and demonstrated to enhance the specificity of oncolytic viruses towards specific cancer cells. A combination of these strategies and other conventional therapies may be more effective than any of those strategies alone.
format Online
Article
Text
id pubmed-7352392
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73523922020-07-15 Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity Hajeri, Praveensingh B. Sharma, Nikita S. Yamamoto, Masato Cancers (Basel) Review Cancer is a major health problem. Most of the treatments exhibit systemic toxicity, as they are not targeted or specific to cancerous cells and tumors. Adenoviruses are very promising gene delivery vectors and have immense potential to deliver targeted therapy. Here, we review a wide range of strategies that have been tried, tested, and demonstrated to enhance the specificity of oncolytic viruses towards specific cancer cells. A combination of these strategies and other conventional therapies may be more effective than any of those strategies alone. MDPI 2020-06-09 /pmc/articles/PMC7352392/ /pubmed/32526919 http://dx.doi.org/10.3390/cancers12061504 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hajeri, Praveensingh B.
Sharma, Nikita S.
Yamamoto, Masato
Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity
title Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity
title_full Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity
title_fullStr Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity
title_full_unstemmed Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity
title_short Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity
title_sort oncolytic adenoviruses: strategies for improved targeting and specificity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352392/
https://www.ncbi.nlm.nih.gov/pubmed/32526919
http://dx.doi.org/10.3390/cancers12061504
work_keys_str_mv AT hajeripraveensinghb oncolyticadenovirusesstrategiesforimprovedtargetingandspecificity
AT sharmanikitas oncolyticadenovirusesstrategiesforimprovedtargetingandspecificity
AT yamamotomasato oncolyticadenovirusesstrategiesforimprovedtargetingandspecificity